A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years

Clinical trial NCT05101486 · COMPLETED

Trial details

NCT number: NCT05101486
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Prevention

Start date: 2021-11-01
Primary completion: 2022-03-28
Enrollment: 755

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.